Royal Bank Of Canada Regeneron Pharmaceuticals, Inc. Transaction History
Royal Bank Of Canada
- $422 Billion
- Q1 2024
A detailed history of Royal Bank Of Canada transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 142,694 shares of REGN stock, worth $140 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
142,694
Previous 261,791
45.49%
Holding current value
$140 Million
Previous $230 Million
40.27%
% of portfolio
0.03%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,426Shares Held
82.1MCall Options Held
835KPut Options Held
1.46M-
Vanguard Group Inc Valley Forge, PA8.93MShares$8.75 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY8.57MShares$8.4 Billion0.19% of portfolio
-
Jpmorgan Chase & CO New York, NY7.73MShares$7.57 Billion0.68% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.75 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.65MShares$4.56 Billion0.76% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $105B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...